Board changes

AI SummaryClose X

CelLBxHealth plc has announced significant board changes, appointing Peter Collins as Chief Executive Officer and Klaas de Boer, Kim Oreskovic, and Benjamin Hart as Non-Executive Directors, effective immediately, to enhance strategic capabilities and drive shareholder value. Concurrently, Joseph Eid will step down as a Non-Executive Director on January 31, 2026. These appointments follow a previous announcement and are intended to leverage the new directors' extensive expertise in life sciences to support the company's focus on circulating tumour cell intelligence for research, drug development, and clinical oncology.

Disclaimer*

UK 100

Latest directors dealings